Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients
Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients
To assess chemotherapy related hyperglycemia in non-diabetic patients, the investigators will
 assess the incidence of hyperglycemia and analyze co-medications and risk factors.
Inclusion Criteria:

 -  Patients with cancers (colorectal, breast) who treated with curative intents and ones
 with malignant lymphoma who are expected to achieve complete remission with
 chemotherapy (mainly, CHOP regimen)

 -  Patients without history of diabetes mellitus

 -  Normal glucose tolerance, as defined in the protocol

 Exclusion Criteria:

 -  Patients with diabetes mellitus or hyperglycemia, as defined in the protocol